DexCom (DXCM) Misses Q2 EPS by 12c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $89.28 +1.54%
Revenue Growth %: +9.9%
Financial Fact:
Development grant and other revenue: 0
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +9.9%
Financial Fact:
Development grant and other revenue: 0
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q2 EPS of ($0.24), $0.12 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $137.3 million versus the consensus estimate of $132.59 million.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Can global equities keep rising? UBS sees these factors driving upside
- Element Solutions (ESI) PT Lowered to $47 at UBS, Buy Rating Maintained
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
